NA

Nikhil Ananth

Healthcare Venture Capital at F-Prime

New York, New York

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $5,000,000.00

Education

Lists including Nikhil

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

FC
F-Prime Capital

2019

  • Senior Associate

    2019

    Venture investing across therapeutics, medical technology, diagnostics, and healthcare technology & services

PB
Project Beacon COVID-19

2020 - 2022

  • Strategy & Business Development

    2020 - 2022

    Social benefit organization founded by the Broad Institute, GV, and F-Prime focused on scaling COVID-19 testing with software and services. Acquired by Ginkgo Bioworks (NYSE: DNA)

AP
Audax Private Equity

2017 - 2019

  • Associate

    2018 - 2019

    Private equity investing across healthcare services, medical products, and software

  • Analyst

    2017 - 2018

Uo
University of Pennsylvania School of Medicine

2016 - 2017

  • Research Associate

    2016 - 2017

    Contributed to preclinical research spun-out to form Cabaletta Bio (NASDAQ: CABA)

WS
Wharton Small Business Development Center

2014 - 2016

  • Consultant

    2014 - 2016

    Healthcare Commercialization

KP
Kite Pharma

2015 - 2015

  • Research Associate

    2015 - 2015